Sex-associated plasma proteomic patterns in relation to HIV reservoir measures and cardiovascular disease: a cross-sectional analysis of the 2000HIV study
BACKGROUND: Sex at birth shapes outcomes during treated HIV infections; males tend to have larger viral reservoirs, while females experience higher HIV-associated cardiovascular disease (CVD) risk. To better understand these differences, we compared the plasma proteome between males and females with HIV. METHODS: Plasma concentrations of 2367 proteins were measured using Olink technology in two independent cohorts of people with HIV (PWH) receiving combination antiretroviral therapy from the 2000HIV study (n = 1728). Sex-specific differentially abundant proteins (sex-DAPs) were identified by linear regression and compared to those in a population-based cohort (UK Biobank) to define HIV-specific sex-DAPs (sex/HIV-DAPs). We assessed the association of these sex/HIV-DAPs with viral reservoir size in the 2000HIV cohort, and with CVD in the UK Biobank. FINDINGS: We identified 484 sex-DAPs, mostly consistent with the UK Biobank. Notably, 24 sex-DAPs were unique to, or showed an opposing effect in PWH (sex/HIV-DAPs). Among these proteins, NK- and T-cell related KLRD1 and TNFRSF9 and programmed cell death-related TNFSF10 were lower in females and positively associated with viral reservoir size, which was higher in males. Additionally, most sex/HIV-DAPs were associated with CVD in the UK Biobank. Notably, increased VWF and reduced ANGPT1 and TNFSF10, seen in females with HIV, were positively associated with CVD in the UK Biobank. INTERPRETATION: Our cross-sectional study suggests that larger viral reservoirs in males are associated with NK- and T-cell related proteins and highlights endothelial and platelet activation as pathways warranting investigation for CVD prevention among females with HIV. FUNDING: ViiV Healthcare.
Authors
- Jéssica Cristina dos Santos (ORCID: https://orcid.org/0000-0001-9191-7356)
- Wilhelm A. J. W. Vos (ORCID: https://orcid.org/0009-0007-3716-4390)
- Vasiliki Matzaraki (ORCID: https://orcid.org/0000-0002-5852-6801)
- Suzanne D. E. Ruijten (ORCID: https://orcid.org/0000-0002-8846-957X)
- Twan Otten (ORCID: https://orcid.org/0000-0003-2880-9111)
- Albert L. Groenendijk (ORCID: https://orcid.org/0000-0002-2072-2532)
- André J. A. M. van der Ven (ORCID: https://orcid.org/0000-0003-1833-3391)
- Mihai G. Netea (ORCID: https://orcid.org/0000-0003-2421-6052)
- Louise E. van Eekeren (ORCID: https://orcid.org/0000-0001-6905-1891)
- Nadira Vadaq (ORCID: https://orcid.org/0000-0002-1746-8844)
- Linos Vandekerckhove (ORCID: https://orcid.org/0000-0002-8600-1631)
- Mareva Delporte (ORCID: https://orcid.org/0000-0002-4423-3012)
- Marc J.T. Blaauw
- Philip G. de Groot
Institutions
- University of Bonn (DE)
- Ghent University Hospital (BE)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Ghent University (BE)
- OLVG (NL)
- Synapse (Netherlands) (NL)
- Elisabeth-TweeSteden Ziekenhuis (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106548
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- ViiV Healthcare